ProShares - Ultra Health Care ETF (RXL) Holdings

이 페이지는 영어 원문에서 AI로 기계 번역되었습니다. 영어 버전이 기준입니다. 영어 버전 읽기

정보 제공만을 목적으로 합니다. 재정적 조언이 아닙니다.

빠른 답변

ProShares - Ultra Health Care (RXL) has a last stored price of $65.97, as of the Oct 23, 2026 trading session. It has a 1.07% expense ratio and $79M in assets under management.

Holdings and weights below are as of Mar 15, 2026. In the stored portfolio snapshot, the largest listed holding is ProShares GENIUS Money Market ETF (IQMM) at 10.73%, and the largest sector allocation is Healthcare at 74.1%.

ProShares - Ultra Health Care (RXL) ETF — Price, Holdings & Analysis

ETF 개요

ProShares Ultra Health Care (RXL) employs a leveraged strategy, seeking to provide two times the daily performance of the S&P Health Care Select Sector Index. This approach is designed for sophisticated investors with a short-term horizon who are looking to capitalize on anticipated daily movements in the health care sector. The fund achieves this through a combination of equity holdings and derivatives. RXL's portfolio is concentrated, with its top holdings including ProShares GENIUS Money Market ETF (IQMM) at 10.73%, Eli Lilly and Co (LLY) at 10.22%, and Johnson & Johnson (JNJ) at 7.33%. Sector allocation is heavily weighted towards Healthcare at 74.1%, followed by Cash & Others at 14.1% and Financial Services at 11.8%. RXL's leveraged nature differentiates it from traditional healthcare ETFs, which typically offer unleveraged exposure to the sector. Investors should understand that leveraged ETFs are not designed for long-term holding and can experience significant volatility.

위험 지표

Investing in RXL involves several risks that investors should carefully consider. As a leveraged ETF, RXL is subject to amplified volatility, meaning that both gains and losses can be magnified. The fund's 3-year beta of 1.06 indicates that it is slightly more volatile than the market. The high expense ratio of 1.07% can create a significant drag on performance over time, especially when compounded by the effects of leverage. RXL's concentration in the health care sector (74.1%) exposes it to sector-specific risks, such as regulatory changes, patent expirations, and shifts in healthcare policy. Furthermore, the fund's top holdings, including Eli Lilly and Johnson & Johnson, represent a significant portion of the portfolio, increasing concentration risk. Due to the fund's leveraged nature, past performance does not guarantee future results.

베타: 1.06

운용보수율

1.07%

RXL은(는) 무엇을 보유하고 있나요?

보유 종목	비중
ProShares GENIUS Money Market ETF (IQMM)	10.73%
Eli Lilly and Co (LLY)	10.22%
Johnson & Johnson (JNJ)	7.33%
AbbVie Inc (ABBV)	5.02%
Merck & Co Inc (MRK)	3.76%
UnitedHealth Group Inc (UNH)	3.25%
Amgen Inc (AMGN)	2.56%
Abbott Laboratories (ABT)	2.48%
Thermo Fisher Scientific Inc (TMO)	2.40%

보유 종목 및 비중: 2026년 3월 15일 기준. 이 펀드 데이터는 45일 이상 지났습니다. 최신 보유 종목은 발행사에서 확인하세요.

펀드는 어떻게 배분되어 있나요?

섹터	비중
헬스케어	74.1%
현금 및 기타	14.1%
금융 서비스	11.8%

국가	비중
미국	83.3%
기타	14.8%
아일랜드	1.8%

배당수익률

0.00%

iShares Morningstar Small-Cap Growth ETF (JKK) — 0.06% expense ratio
ARK Innovation ETF (ARKK) — 0.75% expense ratio
Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
WisdomTree Emerging Markets ESG Fund (DVEM) — 0.32% expense ratio
Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) — 0.59% expense ratio
State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio

ProShares - S&P 500 Dividend Aristocrats ETF (NOBL) (Equity) — 0.35% expense ratio
ProShares - Russell U.S. Dividend Growers ETF (TMDV) (Equity) — 0.35% expense ratio
ProShares - UltraShort Yen (YCS) (Alternatives) — 0.95% expense ratio
ProShares - DJ Brookfield Global Infrastructure ETF (TOLZ) (Equity) — 0.46% expense ratio
ProShares - Online Retail ETF (ONLN) (Equity) — 0.58% expense ratio
ProShares - Ultra Nasdaq Cloud Computing (SKYU) (Equity) — 5.04% expense ratio

질문 및 답변

What is RXL and what does it track?

ProShares Ultra Health Care (RXL) is an exchange-traded fund (ETF) that seeks to provide daily investment results, before fees and expenses, corresponding to two times (2x) the daily performance of the S&P Health Care Select Sector Index.

What is the expense ratio for RXL?

The expense ratio for ProShares Ultra Health Care (RXL) is 1.07%. This means that for every $10,000 invested in the fund, $107 is deducted annually to cover operating expenses.

This expense ratio is significantly higher than the average expense ratio for equity ETFs, which is around 0.44%.

What are the top holdings in RXL?

As of 2026-03-15, the top holdings in ProShares Ultra Health Care (RXL) are: 1) ProShares GENIUS Money Market ETF (IQMM) at 10.73%, which is used for cash management; 2) Eli Lilly and Co (LLY) at 10.22%, a major pharmaceutical company;…

3) Johnson & Johnson (JNJ) at 7.33%, a diversified healthcare company; 4) AbbVie Inc (ABBV) at 5.02%, another leading pharmaceutical company; and 5) Merck & Co Inc (MRK) at 3.76%.

Is RXL a good long-term investment?

ProShares Ultra Health Care (RXL) is generally not considered a suitable long-term investment due to its leveraged nature.

The fund aims to deliver twice the daily performance of the S&P Health Care Select Sector Index, which can lead to amplified gains in the short term. However, the effects of compounding and volatility can significantly erode returns over longer periods.

How does RXL compare to similar ETFs?

RXL differentiates itself from other healthcare ETFs through its leveraged strategy, aiming for twice the daily performance of its benchmark. Most healthcare ETFs offer unleveraged exposure.

RXL's expense ratio of 1.07% is considerably higher than many traditional healthcare ETFs, which typically have expense ratios below 0.50%.

Does RXL pay dividends?

As of 2026-03-15, ProShares Ultra Health Care (RXL) has a dividend yield of 0.00%. This indicates that the fund does not currently distribute any dividends to its shareholders.

Investors seeking income from their investments may want to consider other healthcare ETFs that offer dividend payouts. The fund's focus is primarily on capital appreciation through leveraged exposure to the health care sector, rather than generating income through dividends.

면책 조항: 이 콘텐츠는 정보 제공만을 목적으로 하며 투자 조언을 구성하지 않습니다. 항상 자체 조사를 수행하고 재정 고문과 상담하십시오.

데이터는 정보 제공만을 목적으로 제공됩니다.

이 페이지는 기계가 작성했으며, 페이지별 사람 검수는 거치지 않았습니다. 편집 관리는 체계 차원에서 이루어집니다: 규칙과 출처를 점검하며, 개별 페이지는 점검하지 않습니다.